Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.43 is 22% above its 5-year average of 1.99, near the low end of its 5-year range (0.21–8.95).
As of the fiscal period ended Tuesday, March 31, 2026. 114.05% above its 12-month average of 1.13.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2026 (2026-03-31): 2.43.
QUICK RATIO (ACID-TEST)
2.43
QUICK RATIO (ACID-TEST) AVG TTM
1.13
QUICK RATIO (ACID-TEST) AVG 3Y
0.70
QUICK RATIO (ACID-TEST) AVG 5Y
1.99
QUICK RATIO (ACID-TEST) AVG 10Y
3.16
QUICK RATIO (ACID-TEST) AVG 15Y
12.09
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+114.05%
CURRENT VS 3Y AVG
+247.36%
CURRENT VS 5Y AVG
+21.68%
CURRENT VS 10Y AVG
-23.11%
CURRENT VS 15Y AVG
-79.93%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-27.56%
vs the sector median at left
OKYO Pharma Limited
Market Cap
$56.40M
Quick Ratio (Acid-Test)
2.43
TTM Avg
1.13
3Y Avg
0.70
5Y Avg
1.99
Market Cap
$57.09M
Quick Ratio (Acid-Test)
4.29
TTM Avg
4.53
3Y Avg
3.33
5Y Avg
3.09
Market Cap
$58.16M
Quick Ratio (Acid-Test)
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$58.32M
Quick Ratio (Acid-Test)
9.48
TTM Avg
13.86
3Y Avg
12.45
5Y Avg
13.81
Market Cap
$58.59M
Quick Ratio (Acid-Test)
2.37
TTM Avg
7.60
3Y Avg
7.51
5Y Avg
12.19
Market Cap
$58.94M
Quick Ratio (Acid-Test)
1.23
TTM Avg
0.89
3Y Avg
0.93
5Y Avg
1.06
Market Cap
$59.41M
Quick Ratio (Acid-Test)
6.71
TTM Avg
8.38
3Y Avg
9.61
5Y Avg
10.03
Market Cap
$58.85M
Quick Ratio (Acid-Test)
4.25
TTM Avg
2.40
3Y Avg
3.43
5Y Avg
5.08
Market Cap
$53.75M
Quick Ratio (Acid-Test)
5.31
TTM Avg
2.85
3Y Avg
8.26
5Y Avg
15.41
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OKYO Pharma Limited (OKYO) | $56.40M | 2.43 | 1.13 | 0.70 | 1.99 |
| Talphera, Inc. (TLPH)vs › | $57.09M | 4.29 | 4.53 | 3.33 | 3.09 |
| PDS Biotechnology Corporation (PDSB)vs › | $58.16M | 0.57 | 2.81 | 4.44 | 7.47 |
| Boundless Bio, Inc. (BOLD)vs › | $58.32M | 9.48 | 13.86 | 12.45 | 13.81 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $58.59M | 2.37 | 7.60 | 7.51 | 12.19 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.94M | 1.23 | 0.89 | 0.93 | 1.06 |
| Adicet Bio, Inc. (ACET)vs › | $59.41M | 6.71 | 8.38 | 9.61 | 10.03 |
| Xilio Therapeutics, Inc. (XLO)vs › | $58.85M | 4.25 | 2.40 | 3.43 | 5.08 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.75M | 5.31 | 2.85 | 8.26 | 15.41 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.63M | 12.87 | 3.88 | 3.88 | 3.88 |
Quick Ratio
2.43
Excludes inventory
Current Ratio
2.43
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 2.43 |
| 2025-09-30 | 0.58 |
| 2025-03-31 | 0.40 |
| 2024-09-30 | 0.28 |
| 2024-03-31 | 0.21 |
| 2023-09-30 | 0.28 |
| 2023-03-31 | 0.72 |
| 2022-10-01 | 0.83 |
| 2022-03-31 | 3.17 |
| 2021-09-30 | 8.95 |
| 2021-03-31 | 4.09 |
| 2020-09-30 | 15.14 |
| 2020-03-31 | 0.80 |
| 2019-09-30 | 0.76 |
| 2019-03-31 | 1.78 |
| 2018-09-30 | 7.52 |
| 2018-03-31 | 0.00 |
| 2017-09-30 | 12.03 |
| 2017-03-31 | 0.00 |
| 2016-09-30 | 21.14 |
| 2016-03-31 | 29.62 |
| 2015-09-30 | 28.43 |
| 2015-03-31 | 44.96 |
| 2014-09-30 | 28.31 |
| 2014-03-31 | 49.15 |
| 2013-09-30 | 78.26 |
| 2013-03-31 | 79.50 |
| 2012-09-30 | 43.99 |
| 2012-03-31 | 20.98 |
| 2011-03-31 | 204.35 |
| 2010-09-30 | 392.31 |
| 2010-03-31 | 677.74 |
